RU-486 is an abortifacient which is used to terminate early pregnancy. It acts by blocking progesterone receptor. In our earlier study with progesterone, RU-486 was used as a progesterone receptor antagonist to find out the mechanism of progesterone action on melanoma cells. Results indicated that the effect of progesterone was not mediated through progesterone receptor. In the course of experiment s , it was observed that RU-486 by itself inhibited mouse melanoma cell growth. Further research work with RU-486 showed a dose dependent inhibition of human melanoma cell growth. The mechanism of inhibition of cell growth was due to apoptosis and this effect of RU-486 was neither mediated through progesterone receptor nor glucocorticoid receptor. This in - vitro study suggested that melanoma also could be a target for RU-486 action, apart from breast, ovary and prostate cancers.
Gray-Schopfer, V., Wellbrock, C. and Marais, R. (2007) Melanoma Biology and New Targeted Therapy. Nature, 445, 851-857. https://doi.org/10.1038/nature05661
Tan, Y.M., Yu, R. and Pezzuto, J.M. (2003) Betulinic Acid-Induced Programmed Cell Death in Human Melanoma Cells Involves Mitogen-Activated Protein Kinase Activation. Clinical Cancer Research, 9, 2866-2875.
Vyas, V.K., Brahmbhatt, K., Bhatt, H. and Parmar, U. (2013) Therapeutic Potential of Snake Venom in Cancer Therapy: Current Perspectives. Asian Pacific Journal of Tropical Biomedicine, 3, 156-162. https://doi.org/10.1016/S2221-1691(13)60042-8
Ramaraj, P. and Cox, J.L. (2014) In-Vitro Effect of Progesterone on Human Melanoma (BLM) Cell Growth. International Journal of Clinical and Experimental Medicine, 7, 3941-3953.
Weiss, B.D. (1993) RU-486: The Progesterone Antagonist. Archives of Family Medicine, 2, 63-70. https://doi.org/10.1001/archfami.2.1.63
Baulieu, E.E. (1991) The Steroid Hormone Antagonist RU-486: Mechanism at the Cellular Level and Clinical Applications. Endocrinology and Metabolism Clinics of North America, 20, 873-891.
Ulmann, A. (1987) The Antiprogestins: A Recent Advance in Fertility Regulation. Journal of Steroid Biochemistry, 27, 1009-1012. https://doi.org/10.1016/0022-4731(87)90182-8
Brandhagen, B.N., Tieszen, C.R., Ulmer, T.M., Tracy, M.S., Goyeneche, A.A. and Telleria, C.M. (2013) Cytostasis and Morphological Changes Induced by Mifepristone in Human Metastatic Cancer Cells Involve Cytotoskeletal Filamentous Actin Reorganization and Impairment of Cell Adhesion Dynamics. BMC Cancer, 13, 35. https://doi.org/10.1186/1471-2407-13-35
Taplin, M.E., Manola, J., Oh, W.K., Kantoff, P.W., Bubley, G.J., Smith, M., Barb, D., Mantzoros, C., Gelmann, E.P. and Balk, S.P. (2008) A Phase II Study of Mifepristone (RU-486) in Castration-Resistant Prostate Cancer, with a Correlative Assessment of Androgen-Related Hormones. BJU International, 101, 1084-1089. https://doi.org/10.1111/j.1464-410X.2008.07509.x
Ramaraj, P. and Cox, J.L. (2014) In Vitro Effect of Sex Steroids on Mouse Melanoma (B16F10) Cell Growth. CellBio, 3, 60-71. https://doi.org/10.4236/cellbio.2014.32007
Mosmann, T. (1983) Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. Journal of Immunological Methods, 65, 55-63. https://doi.org/10.1016/0022-1759(83)90303-4
Macleod, K.G. and Langdon, S.P. (2004) Viable Cell Counting Using Trypan Blue. In: Langdon, S.P., Ed., Cancer Cell Culture Methods and Protocols, Humana Press, Totowa, pp. 26.
Li, X., Melmed, M.R. and Darzynkiewiz, Z. (1996) Detection of Apoptosis and DNA Replication by Different Labeling of DNA Strands with Fluorochromes of Different Cells. Experimental Cell Research, 222, 28-37. https://doi.org/10.1006/excr.1996.0004
Hughes, D. and Mehmet, H. (2003) Protocol 11.9: Detection of High Molecular Weight DNA Fragments by Gel Electrophoresis. In: Hughes, D. and Mehmet, H., Eds., Cell Proliferation & Apoptosis, BIOS Scientific Publishers, Ltd., Oxford, 312.
Nicholson, D.W., et al. (1995) Identification and Inhibition of the ICE/CED-3 Protease Necessary for Mammalian Apoptosis. Nature, 376, 37-43. https://doi.org/10.1038/376037a0
Seglen, P.O. and Gordon, P.B. (1982) 3-Methyladenine: Specific Inhibitior of Autophagic/Lysosomal Protein Degradation in Isolated Rat Hepatocytes. Proceedings of the National Academy of Sciences, 79, 1889-1892. https://doi.org/10.1073/pnas.79.6.1889
Jagannath, C., Lindsey, D.R., Dhandayuthapani, S., Xu, Y., Hunter, R.L.J. and Eissa, N.T. (2009) Autophagy Enhances the Efficacy of BCG Vaccine by Increasing Peptide Presentation in Mouse Dendritic Cells. Nature Medicine, 15, 267-276. https://doi.org/10.1038/nm.1928
Madeo, F., Eisenberg, T., Butner, S., Ruckenstuhl, C. and Kroener, G. (2010) Spermidine—A Novel Autophagy Inducer and Longevity Elixir. Autophagy, 6, 160-162. https://doi.org/10.4161/auto.6.1.10600
Morselli, E., et al. (2011) Spermidine and Resveratrol Induce Autophagy by Distinct Pathways Converging on the Acetylproteome. The Journal of Cell Biology, 192, 615-629. https://doi.org/10.1083/jcb.201008167
Gaddy, V., Barrett, J., Delk, J., Kallab, A., Porte, A. and Schoenlein, P. (2004) Mifepristone Induces Growth Arrest, Caspase Activation, and Apoptosis of Estrogen Receptor-Expressing, Antiestrogen-Resistant Breast Cancer Cells. Clinical Cancer Research, 10, 5215-5225. https://doi.org/10.1158/1078-0432.CCR-03-0637
Fang, X., Zhang, X., Zhou, M. and Li, J. (2010) Effects of Progesterone on the Growth Regulation in Classical Progesterone Receptor-Negative Malignant Melanoma Cells. Journal of Huazhong University of Science and Technology [Medical Sciences], 30, 231-234. https://doi.org/10.1007/s11596-010-0220-3
Atif, F., et al. (2011) Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and in Vivo Evidence. Molecular Medicine, 17, 1084-1094. https://doi.org/10.2119/molmed.2010.00255
Dupin, E. (2011) Phenotypic Plasticity of Neural Crest-Derived Melanocytes and Schwann Cells. Biologie Aujourd’hui, 205, 53-61. https://doi.org/10.1051/jbio/2011008